Literature DB >> 23219711

Sinonasal adenoid cystic carcinomas: clinical outcomes and predictive factors.

J Michel1, N Fakhry, L Santini, J Mancini, A Giovanni, P Dessi.   

Abstract

This is a retrospective study of 11 patients treated for sinonasal adenoid cystic carcinomas (ACCs) between 1989 and 2008. The authors statistically analysed the epidemiological, clinical, histological and therapeutic aspects of this series of patients with sinonasal ACCs and their impact in terms of overall and disease-free survival established using the Kaplan-Meier method. A search for prognostic factors was made using a log-rank test. There were 5 women (45.4%) and 6 men (54.6%). Average age at diagnosis was 52.2 years (24-75 years). Mean follow-up of patients was 63 months (11-142 months). Tumours were classified as T1 in 9%, T2 in 45.4% and T4 in 45.4% of cases. Disease-free survival rates at 1, 5 and 10 years were 83%, 41% and 18%, respectively, and overall survival rates were 100%, 64% and 35%, respectively. Surgery followed or not by radiotherapy resulted in better survival than other treatment, regardless of tumour stage. Better disease-free survival with postoperative radiotherapy was not found. These tumours should be treated by surgical resection with clear margins followed by adjuvant radiotherapy.
Copyright © 2012 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23219711     DOI: 10.1016/j.ijom.2012.11.007

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  4 in total

1.  The endoscopic endonasal approach for sinonasal and nasopharyngeal adenoid cystic carcinoma.

Authors:  Ryota Kashiwazaki; Meghan T Turner; Mathew Geltzeiler; Juan C Fernandez-Miranda; Paul A Gardner; Carl H Snyderman; Eric W Wang
Journal:  Laryngoscope       Date:  2019-06-13       Impact factor: 3.325

2.  [Clinical features of advanced adenoid cystic carcinoma in the nasal cavity and paranasal sinuses: analysis of 21 cases].

Authors:  Hui-Gang Wang; Cong-Xiang Shen; Fang Chen; Guan-Xue Li; Xiao-Qi Wang; Zhong Wen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

3.  Minimally invasive endoscopic resection for the treatment of sinonasal malignancy: the outcomes and risk factors for recurrence.

Authors:  Ning He; Xiaohong Chen; Luo Zhang; Xuejun Chen; Zhigang Huang; Qi Zhong; Hongzhi Ma; Ling Feng; Lizhen Hou; Jugao Fang
Journal:  Ther Clin Risk Manag       Date:  2017-05-03       Impact factor: 2.423

4.  Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.

Authors:  Yi-Chan Lee; Ta-Jen Lee; Ngan-Ming Tsang; Yenlin Huang; Cheng-Lung Hsu; Li-Jen Hsin; Yi-Hsuan Lee; Kai-Ping Chang
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.